News
AstraZeneca has turned to another digital health partner to support its aspirations in chronic kidney disease (CKD), joining ...
The $8-per-share deal will give Sanofi control of Vigil's VG-3927, an oral drug candidate for Alzheimer's that acts as an ...
NICE is also looking at the role of Hympavzi in treating severe haemophilia A, where there are other subcutaneous options ...
According to the CDC, cases of myocarditis and pericarditis are rare with the vaccines and in most cases resolve within a few ...
For J&J, there was a positive outcome as the Oncologic Drugs Advisory Committee (ODAC) voted six to two in favour of approval ...
Arguably, the step historically limiting growth of the radiotherapeutics sector is radioisotope generation. Isotopes are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results